Here’s a startling fact: in Mongolia, 20 out of every 100 women newly diagnosed with cervical cancer face a battle that could have been prevented. This grim statistic was brought to light during a recent awareness event in Ulaanbaatar, where experts shed light on the critical role of human papillomavirus (HPV) vaccination and early screening. But here’s where it gets even more alarming: Mongolia ranks among the countries with the highest cervical cancer incidence and mortality rates globally. Why? Because, as Associate Professor Dr. N.Erdenekhuu emphasized, the country’s cervical cancer mortality rate is nearly double the world average, and a staggering 60% of diagnosed women die within a year due to late detection.
Dr. Erdenekhuu’s talk, titled The Importance of Immunization against Human Papillomavirus, underscored a crucial point: vaccination is the only scientifically proven method to prevent most cervical cancers. HPV, the culprit behind 94–96% of cervical cancer cases, infects about eight out of 10 people at some point in their lives. While there are over 200 types of HPV, just three—types 16, 18, and 45—are responsible for 70–80% of cervical cancers. Here’s the silver lining: a healthy immune system can often clear the infection within 1–3 years, preventing cancer. But here’s the part most people miss: 5–10% of persistent infections can progress to cancer within a decade, spreading to other organs if left unchecked.
So, what’s the solution? Early screening and vaccination of girls aged 9–14 are the most effective strategies to combat this preventable disease. Mongolia took a significant step in 2024 by adding the HPV vaccine to its national routine immunization program for 11-year-olds. Additionally, family clinics now offer cervical screening for women aged 30–60. Yet, despite these advancements, the challenge remains: how do we ensure widespread vaccine uptake and early detection? During the event, attended by about 60 people, health experts reiterated the urgent need for action to reverse Mongolia’s high cervical cancer burden.
But here’s the controversial question: Why is cervical cancer still a leading cause of death in Mongolia when we have the tools to prevent it? Is it a lack of awareness, limited access to healthcare, or something else entirely? And what role should individuals, communities, and policymakers play in addressing this crisis? Let’s start the conversation—share your thoughts in the comments below. Together, we can turn the tide on this preventable tragedy.
